Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Ates LS"'
Autor:
Pidot SJ; Department of Microbiology and Immunology, Peter Doherty Institute for Infection and Immunity, University of Melbourne, Melbourne, Australia., Klatt S; Department of Molecular Biology and Biochemistry, Bio21 Institute, University of Melbourne, Parkville, Australia., Ates LS; Institut Pasteur, Université Paris Cité, Unit for Integrated Mycobacterial Pathogenomics, Paris, France., Frigui W; Institut Pasteur, Université Paris Cité, Unit for Integrated Mycobacterial Pathogenomics, Paris, France., Sayes F; Institut Pasteur, Université Paris Cité, Unit for Integrated Mycobacterial Pathogenomics, Paris, France., Majlessi L; Institut Pasteur, Université Paris Cité, Unit for Integrated Mycobacterial Pathogenomics, Paris, France., Izumi H; School of Chemistry and Molecular Biosciences, University of Queensland, Brisbane, Australia., Monk IR; Department of Microbiology and Immunology, Peter Doherty Institute for Infection and Immunity, University of Melbourne, Melbourne, Australia., Porter JL; Department of Microbiology and Immunology, Peter Doherty Institute for Infection and Immunity, University of Melbourne, Melbourne, Australia., Bennett-Wood V; Department of Microbiology and Immunology, Peter Doherty Institute for Infection and Immunity, University of Melbourne, Melbourne, Australia., Seemann T; Department of Microbiology and Immunology, Peter Doherty Institute for Infection and Immunity, University of Melbourne, Melbourne, Australia., Otter A; UK Health Security Agency, Porton Down, Salisbury, United Kingdom., Taiaroa G; Department of Microbiology and Immunology, University of Otago, Dunedin, New Zealand., Cook GM; Department of Microbiology and Immunology, University of Otago, Dunedin, New Zealand., West N; School of Chemistry and Molecular Biosciences, University of Queensland, Brisbane, Australia., Tobias NJ; Department of Microbiology and Immunology, Peter Doherty Institute for Infection and Immunity, University of Melbourne, Melbourne, Australia., Fuerst JA; School of Chemistry and Molecular Biosciences, University of Queensland, Brisbane, Australia., Stutz MD; Walter and Eliza Hall Institute of Medical Research, Parkville, Australia., Pellegrini M; Walter and Eliza Hall Institute of Medical Research, Parkville, Australia., McConville M; Department of Molecular Biology and Biochemistry, Bio21 Institute, University of Melbourne, Parkville, Australia., Brosch R; Institut Pasteur, Université Paris Cité, Unit for Integrated Mycobacterial Pathogenomics, Paris, France., Stinear TP; Department of Microbiology and Immunology, Peter Doherty Institute for Infection and Immunity, University of Melbourne, Melbourne, Australia.
Publikováno v:
PLoS pathogens [PLoS Pathog] 2024 Aug 29; Vol. 20 (8), pp. e1012440. Date of Electronic Publication: 2024 Aug 29 (Print Publication: 2024).
Autor:
Waanders L; Department of Medical Microbiology and Infection Control, Amsterdam UMC Locatie VUmc, Amsterdam, The Netherlands.; Amsterdam institute for Infection and Immunity, Infectious Diseases, Amsterdam, Netherlands.; Cancer Center Amsterdam, Cancer Immunology, Amsterdam, Netherlands., van der Donk LEH; Amsterdam institute for Infection and Immunity, Infectious Diseases, Amsterdam, Netherlands.; Department of Experimental Immunology, Amsterdam UMC Locatie AMC, Amsterdam, The Netherlands., Ates LS; Department of Experimental Immunology, Amsterdam UMC Locatie AMC, Amsterdam, The Netherlands., Maaskant J; Department of Medical Microbiology and Infection Control, Amsterdam UMC Locatie VUmc, Amsterdam, The Netherlands., van Hamme JL; Amsterdam institute for Infection and Immunity, Infectious Diseases, Amsterdam, Netherlands.; Department of Experimental Immunology, Amsterdam UMC Locatie AMC, Amsterdam, The Netherlands., Eldering E; Amsterdam institute for Infection and Immunity, Infectious Diseases, Amsterdam, Netherlands.; Cancer Center Amsterdam, Cancer Immunology, Amsterdam, Netherlands.; Department of Experimental Immunology, Amsterdam UMC Locatie AMC, Amsterdam, The Netherlands.; Amsterdam institute for Infection and Immunity, Cancer Immunology, Amsterdam, Netherlands.; The Lymphoma and Myeloma Center Amsterdam, LYMMCARE, Amsterdam, Netherlands., van Bruggen JAC; Amsterdam institute for Infection and Immunity, Infectious Diseases, Amsterdam, Netherlands.; Cancer Center Amsterdam, Cancer Immunology, Amsterdam, Netherlands.; Department of Experimental Immunology, Amsterdam UMC Locatie AMC, Amsterdam, The Netherlands.; Amsterdam institute for Infection and Immunity, Cancer Immunology, Amsterdam, Netherlands., Rietveld JM; Amsterdam institute for Infection and Immunity, Infectious Diseases, Amsterdam, Netherlands.; Cancer Center Amsterdam, Cancer Immunology, Amsterdam, Netherlands.; Department of Experimental Immunology, Amsterdam UMC Locatie AMC, Amsterdam, The Netherlands.; Amsterdam institute for Infection and Immunity, Cancer Immunology, Amsterdam, Netherlands., Bitter W; Department of Medical Microbiology and Infection Control, Amsterdam UMC Locatie VUmc, Amsterdam, The Netherlands.; Amsterdam institute for Infection and Immunity, Infectious Diseases, Amsterdam, Netherlands.; Amsterdam institute for Life and Environment, Vrije Universiteit, Amsterdam, Netherlands., Geijtenbeek TBH; Amsterdam institute for Infection and Immunity, Infectious Diseases, Amsterdam, Netherlands c.kuijl@amsterdamumc.nl t.b.geijtenbeek@amsterdamumc.nl.; Department of Experimental Immunology, Amsterdam UMC Locatie AMC, Amsterdam, The Netherlands., Kuijl CP; Department of Medical Microbiology and Infection Control, Amsterdam UMC Locatie VUmc, Amsterdam, The Netherlands c.kuijl@amsterdamumc.nl t.b.geijtenbeek@amsterdamumc.nl.; Amsterdam institute for Infection and Immunity, Infectious Diseases, Amsterdam, Netherlands.; Cancer Center Amsterdam, Cancer Immunology, Amsterdam, Netherlands.
Publikováno v:
Journal for immunotherapy of cancer [J Immunother Cancer] 2023 Apr; Vol. 11 (4).
Autor:
van der Donk LEH; Department of Experimental Immunology, Amsterdam institute for Infection and Immunity, Amsterdam UMC, University of Amsterdam, Meibergdreef 9, Amsterdam 1105 AZ, the Netherlands., van der Spek J; Department of Experimental Immunology, Amsterdam institute for Infection and Immunity, Amsterdam UMC, University of Amsterdam, Meibergdreef 9, Amsterdam 1105 AZ, the Netherlands., van Duivenvoorde T; Department of Experimental Immunology, Amsterdam institute for Infection and Immunity, Amsterdam UMC, University of Amsterdam, Meibergdreef 9, Amsterdam 1105 AZ, the Netherlands., Ten Brink MS; Division of Infectious Diseases and Center of Experimental and Molecular Medicine, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam 1105 AZ, the Netherlands., Geijtenbeek TBH; Department of Experimental Immunology, Amsterdam institute for Infection and Immunity, Amsterdam UMC, University of Amsterdam, Meibergdreef 9, Amsterdam 1105 AZ, the Netherlands., Kuijl CP; Medical Microbiology and Infection Control, Cancer Center Amsterdam, Amsterdam UMC, Vrije Universiteit Amsterdam, De Boelelaan 1117, Amsterdam 1081 HV, the Netherlands., van Heijst JWJ; Department of Experimental Immunology, Amsterdam institute for Infection and Immunity, Amsterdam UMC, University of Amsterdam, Meibergdreef 9, Amsterdam 1105 AZ, the Netherlands., Ates LS; Department of Experimental Immunology, Amsterdam institute for Infection and Immunity, Amsterdam UMC, University of Amsterdam, Meibergdreef 9, Amsterdam 1105 AZ, the Netherlands.; Medical Microbiology and Infection Control, Cancer Center Amsterdam, Amsterdam UMC, Vrije Universiteit Amsterdam, De Boelelaan 1117, Amsterdam 1081 HV, the Netherlands.
Publikováno v:
Biology open [Biol Open] 2022 Feb 15; Vol. 11 (2). Date of Electronic Publication: 2022 Mar 01.
Separate signaling events control TCR downregulation and T cell activation in primary human T cells.
Autor:
van der Donk LEH; Department of Experimental Immunology, Amsterdam Infection and Immunity Institute, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands., Ates LS; Department of Experimental Immunology, Amsterdam Infection and Immunity Institute, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands., van der Spek J; Department of Experimental Immunology, Amsterdam Infection and Immunity Institute, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands., Tukker LM; Department of Experimental Immunology, Amsterdam Infection and Immunity Institute, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands., Geijtenbeek TBH; Department of Experimental Immunology, Amsterdam Infection and Immunity Institute, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands., van Heijst JWJ; Department of Experimental Immunology, Amsterdam Infection and Immunity Institute, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.; Neogene Therapeutics, Amsterdam, The Netherlands.
Publikováno v:
Immunity, inflammation and disease [Immun Inflamm Dis] 2021 Mar; Vol. 9 (1), pp. 223-238. Date of Electronic Publication: 2020 Dec 22.
Autor:
Orgeur M; Institut Pasteur, Unit for Integrated Mycobacterial Pathogenomics, CNRS UMR 3525, Paris 75015, France., Frigui W; Institut Pasteur, Unit for Integrated Mycobacterial Pathogenomics, CNRS UMR 3525, Paris 75015, France., Pawlik A; Institut Pasteur, Unit for Integrated Mycobacterial Pathogenomics, CNRS UMR 3525, Paris 75015, France., Clark S; Public Health England, Porton Down, Salisbury SP4 0JG, UK., Williams A; Public Health England, Porton Down, Salisbury SP4 0JG, UK., Ates LS; Institut Pasteur, Unit for Integrated Mycobacterial Pathogenomics, CNRS UMR 3525, Paris 75015, France.; Amsterdam UMC, University of Amsterdam, Department of Experimental Immunology, Amsterdam institute for Infection & Immunity, Meibergdreef 9, Amsterdam, Netherlands., Ma L; Institut Pasteur, Biomics, C2RT, Paris 75015, France., Bouchier C; Institut Pasteur, Biomics, C2RT, Paris 75015, France., Parkhill J; Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton CB10 1SA, UK.; Department of Veterinary Medicine, University of Cambridge, Cambridge CB3 0ES, UK., Brodin P; CIIL - Center for Infection and Immunity of Lille, Université de Lille/CNRS UMR 9017/INSERM U1019/CHU Lille/Institut Pasteur de Lille, Lille 59000, France., Brosch R; Institut Pasteur, Unit for Integrated Mycobacterial Pathogenomics, CNRS UMR 3525, Paris 75015, France.
Publikováno v:
Microbial genomics [Microb Genom] 2021 Feb; Vol. 7 (2).
Autor:
Ates LS; Department of Experimental Immunology, Amsterdam Infection & Immunity Institute, Amsterdam UMC, University of Amsterdam, Meibergdreef 9, Amsterdam, the Netherlands.
Publikováno v:
Molecular microbiology [Mol Microbiol] 2020 Jan; Vol. 113 (1), pp. 4-21. Date of Electronic Publication: 2019 Nov 24.
Autor:
Burggraaf MJ; Medical Microbiology and Infection Control, Cancer Center Amsterdam, Amsterdam UMC, Vrije Universiteit Amsterdam, De Boelelaan 1117, Amsterdam, Netherlands., Ates LS; Medical Microbiology and Infection Control, Cancer Center Amsterdam, Amsterdam UMC, Vrije Universiteit Amsterdam, De Boelelaan 1117, Amsterdam, Netherlands.; Department of Experimental Immunology, Amsterdam Infection & Immunity Institute, Amsterdam UMC, University of Amsterdam, Meibergdreef 9, Amsterdam, Netherlands., Speer A; Medical Microbiology and Infection Control, Cancer Center Amsterdam, Amsterdam UMC, Vrije Universiteit Amsterdam, De Boelelaan 1117, Amsterdam, Netherlands., van der Kuij K; Medical Microbiology and Infection Control, Cancer Center Amsterdam, Amsterdam UMC, Vrije Universiteit Amsterdam, De Boelelaan 1117, Amsterdam, Netherlands., Kuijl C; Medical Microbiology and Infection Control, Cancer Center Amsterdam, Amsterdam UMC, Vrije Universiteit Amsterdam, De Boelelaan 1117, Amsterdam, Netherlands., Bitter W; Medical Microbiology and Infection Control, Cancer Center Amsterdam, Amsterdam UMC, Vrije Universiteit Amsterdam, De Boelelaan 1117, Amsterdam, Netherlands. w.bitter@vumc.nl.; Molecular Microbiology, Vrije Universiteit Amsterdam, de Boelelaan 1105, Amsterdam, Netherlands. w.bitter@vumc.nl.
Publikováno v:
Microbial cell factories [Microb Cell Fact] 2019 Mar 06; Vol. 18 (1), pp. 44. Date of Electronic Publication: 2019 Mar 06.
Autor:
Ates LS; Department of Genomes and Genetics, Institut Pasteur, Unit for Integrated Mycobacterial Pathogenomics, CNRS UMR3525, Paris, France.; Department of Experimental Immunology, Amsterdam UMC, University of Amsterdam, Amsterdam Infection & Immunity Institute, Amsterdam, The Netherlands., Dippenaar A; DST-NRF Centre of Excellence for Biomedical Tuberculosis Research; South African Medical Research Council Centre for Tuberculosis Research; Division of Molecular Biology and Human Genetics, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South Africa., Sayes F; Department of Genomes and Genetics, Institut Pasteur, Unit for Integrated Mycobacterial Pathogenomics, CNRS UMR3525, Paris, France., Pawlik A; Department of Genomes and Genetics, Institut Pasteur, Unit for Integrated Mycobacterial Pathogenomics, CNRS UMR3525, Paris, France., Bouchier C; Department of Genomes and Genetics, Institut Pasteur, Genomics Platform, Paris, France., Ma L; Department of Genomes and Genetics, Institut Pasteur, Genomics Platform, Paris, France., Warren RM; DST-NRF Centre of Excellence for Biomedical Tuberculosis Research; South African Medical Research Council Centre for Tuberculosis Research; Division of Molecular Biology and Human Genetics, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South Africa., Sougakoff W; Sorbonne Universités, INSERM, Centre d'Immunologie et des Maladies Infectieuses, CIMI-Paris, Team 13 (Bacteriology), Paris, France.; Laboratoire de Bactériologie-Hygiène, Centre National de Référence des Mycobactéries (NRC MyRMA), Hôpitaux Universitaires Pitié-Salpêtrière - Charles Foix, Paris, France., Majlessi L; Department of Genomes and Genetics, Institut Pasteur, Unit for Integrated Mycobacterial Pathogenomics, CNRS UMR3525, Paris, France., van Heijst JWJ; Department of Experimental Immunology, Amsterdam UMC, University of Amsterdam, Amsterdam Infection & Immunity Institute, Amsterdam, The Netherlands., Brossier F; Department of Genomes and Genetics, Institut Pasteur, Unit for Integrated Mycobacterial Pathogenomics, CNRS UMR3525, Paris, France.; Sorbonne Universités, INSERM, Centre d'Immunologie et des Maladies Infectieuses, CIMI-Paris, Team 13 (Bacteriology), Paris, France.; Laboratoire de Bactériologie-Hygiène, Centre National de Référence des Mycobactéries (NRC MyRMA), Hôpitaux Universitaires Pitié-Salpêtrière - Charles Foix, Paris, France., Brosch R; Department of Genomes and Genetics, Institut Pasteur, Unit for Integrated Mycobacterial Pathogenomics, CNRS UMR3525, Paris, France.
Publikováno v:
Genome biology and evolution [Genome Biol Evol] 2018 Aug 01; Vol. 10 (8), pp. 1858-1874.
Autor:
Ates LS; Institut Pasteur, Unit for Integrated Mycobacterial Pathogenomics, CNRS UMR3525, Paris, France.; Department of Experimental Immunology, Academic Medical Center, University of Amsterdam, Amsterdam, the Netherlands., Sayes F; Institut Pasteur, Unit for Integrated Mycobacterial Pathogenomics, CNRS UMR3525, Paris, France., Frigui W; Institut Pasteur, Unit for Integrated Mycobacterial Pathogenomics, CNRS UMR3525, Paris, France., Ummels R; Department of Medical Microbiology and Infection Prevention, VU University Medical Center, Amsterdam, the Netherlands., Damen MPM; Institut Pasteur, Unit for Integrated Mycobacterial Pathogenomics, CNRS UMR3525, Paris, France.; Section Molecular Microbiology, Amsterdam Institute of Molecules, Medicine & Systems, Vrije Universiteit, Amsterdam, the Netherlands., Bottai D; University of Pisa, Department of Biology, Pisa, Italy., Behr MA; McGill International TB Centre, Infectious Diseases and Immunity in Global Health Program at the McGill University Health Centre Research Institute, Montreal, Canada., van Heijst JWJ; Department of Experimental Immunology, Academic Medical Center, University of Amsterdam, Amsterdam, the Netherlands., Bitter W; Department of Medical Microbiology and Infection Prevention, VU University Medical Center, Amsterdam, the Netherlands.; Section Molecular Microbiology, Amsterdam Institute of Molecules, Medicine & Systems, Vrije Universiteit, Amsterdam, the Netherlands., Majlessi L; Institut Pasteur, Unit for Integrated Mycobacterial Pathogenomics, CNRS UMR3525, Paris, France., Brosch R; Institut Pasteur, Unit for Integrated Mycobacterial Pathogenomics, CNRS UMR3525, Paris, France.
Publikováno v:
PLoS pathogens [PLoS Pathog] 2018 Jun 18; Vol. 14 (6), pp. e1007139. Date of Electronic Publication: 2018 Jun 18 (Print Publication: 2018).
Autor:
Sayes F; Institut Pasteur, Unit for Integrated Mycobacterial Pathogenomics, CNRS UMR 3525, 25 rue du Dr. Roux, Paris 75015, France., Blanc C; Institut Pasteur, Unit for Molecular Virology and Vaccinology, 28 rue du Dr. Roux, Paris 75015, France., Ates LS; Institut Pasteur, Unit for Integrated Mycobacterial Pathogenomics, CNRS UMR 3525, 25 rue du Dr. Roux, Paris 75015, France., Deboosere N; Université de Lille, CNRS UMR 8204, INSERM U1019, CHU Lille, Institut Pasteur de Lille, Center for Infection and Immunity of Lille (CIIL), 1 rue du Professeur Calmette, 59000 Lille, France., Orgeur M; Institut Pasteur, Unit for Integrated Mycobacterial Pathogenomics, CNRS UMR 3525, 25 rue du Dr. Roux, Paris 75015, France., Le Chevalier F; Institut Pasteur, Unit for Integrated Mycobacterial Pathogenomics, CNRS UMR 3525, 25 rue du Dr. Roux, Paris 75015, France., Gröschel MI; Institut Pasteur, Unit for Integrated Mycobacterial Pathogenomics, CNRS UMR 3525, 25 rue du Dr. Roux, Paris 75015, France., Frigui W; Institut Pasteur, Unit for Integrated Mycobacterial Pathogenomics, CNRS UMR 3525, 25 rue du Dr. Roux, Paris 75015, France., Song OR; Université de Lille, CNRS UMR 8204, INSERM U1019, CHU Lille, Institut Pasteur de Lille, Center for Infection and Immunity of Lille (CIIL), 1 rue du Professeur Calmette, 59000 Lille, France., Lo-Man R; Institut Pasteur, Neonatal Immunity Group, Unit for Human Histopathology and Animal Models, 28 rue du Dr. Roux, Paris 75015, France., Brossier F; Institut Pasteur, Unit for Integrated Mycobacterial Pathogenomics, CNRS UMR 3525, 25 rue du Dr. Roux, Paris 75015, France; Sorbonne Universités, UPMC University of Paris 06, CIMI-Paris, AP-HP, Hôpital Pitié-Salpêtrière, CNR-MyRMA, Paris, France., Sougakoff W; Sorbonne Universités, UPMC University of Paris 06, CIMI-Paris, AP-HP, Hôpital Pitié-Salpêtrière, CNR-MyRMA, Paris, France., Bottai D; University of Pisa, Department of Biology, via S. Zeno 35-39, 56127 Pisa, Italy., Brodin P; Université de Lille, CNRS UMR 8204, INSERM U1019, CHU Lille, Institut Pasteur de Lille, Center for Infection and Immunity of Lille (CIIL), 1 rue du Professeur Calmette, 59000 Lille, France., Charneau P; Institut Pasteur, Unit for Molecular Virology and Vaccinology, 28 rue du Dr. Roux, Paris 75015, France., Brosch R; Institut Pasteur, Unit for Integrated Mycobacterial Pathogenomics, CNRS UMR 3525, 25 rue du Dr. Roux, Paris 75015, France., Majlessi L; Institut Pasteur, Unit for Integrated Mycobacterial Pathogenomics, CNRS UMR 3525, 25 rue du Dr. Roux, Paris 75015, France. Electronic address: laleh.majlessi@pasteur.fr.
Publikováno v:
Cell reports [Cell Rep] 2018 Apr 24; Vol. 23 (4), pp. 1072-1084.